Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuko Sakai

Showing results (91-100 of 95) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 95 results.
Nature|August 13, 2009
In vitro and in vivo characterization of new swine-origin H1N1 influenza virusesYasushi Itoh, Kyoko Shinya, Maki Kiso, et al.
Nature|May 16, 2022
Characterization and antiviral susceptibility of SARS-CoV-2 Omicron BA.2Ryuta Uraki, Maki Kiso, Shun Iida, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 18, 2021
Characterization of a new SARS-CoV-2 variant that emerged in BrazilMasaki Imai, Peter J Halfmann, Seiya Yamayoshi, et al.
Research Square|January 4, 2022
The SARS-CoV-2 B.1.1.529 Omicron virus causes attenuated infection and disease in mice and hamstersMichael Diamond, Peter Halfmann, Tadashi Maemura, et al.
Nature|January 21, 2022
SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamstersPeter J Halfmann, Shun Iida, Kiyoko Iwatsuki-Horimoto, et al.
Pageof 10

Showing results (91-100 of 95) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 95 results.
Nature|August 13, 2009
In vitro and in vivo characterization of new swine-origin H1N1 influenza virusesYasushi Itoh, Kyoko Shinya, Maki Kiso, et al.
Nature|May 16, 2022
Characterization and antiviral susceptibility of SARS-CoV-2 Omicron BA.2Ryuta Uraki, Maki Kiso, Shun Iida, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 18, 2021
Characterization of a new SARS-CoV-2 variant that emerged in BrazilMasaki Imai, Peter J Halfmann, Seiya Yamayoshi, et al.
Research Square|January 4, 2022
The SARS-CoV-2 B.1.1.529 Omicron virus causes attenuated infection and disease in mice and hamstersMichael Diamond, Peter Halfmann, Tadashi Maemura, et al.
Nature|January 21, 2022
SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamstersPeter J Halfmann, Shun Iida, Kiyoko Iwatsuki-Horimoto, et al.
Pageof 10